273 related articles for article (PubMed ID: 17908954)
1. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy.
Germain D; Frank DA
Clin Cancer Res; 2007 Oct; 13(19):5665-9. PubMed ID: 17908954
[TBL] [Abstract][Full Text] [Related]
2. STAT proteins: novel molecular targets for cancer drug discovery.
Turkson J; Jove R
Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
[TBL] [Abstract][Full Text] [Related]
3. STAT3 as a central mediator of neoplastic cellular transformation.
Frank DA
Cancer Lett; 2007 Jun; 251(2):199-210. PubMed ID: 17129668
[TBL] [Abstract][Full Text] [Related]
4. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
[TBL] [Abstract][Full Text] [Related]
5. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
Haura EB; Turkson J; Jove R
Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
8. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
9. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
[TBL] [Abstract][Full Text] [Related]
10. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications.
Huang S
Clin Cancer Res; 2007 Mar; 13(5):1362-6. PubMed ID: 17332277
[TBL] [Abstract][Full Text] [Related]
11. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
[TBL] [Abstract][Full Text] [Related]
12. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis.
Kim DJ; Chan KS; Sano S; Digiovanni J
Mol Carcinog; 2007 Aug; 46(8):725-31. PubMed ID: 17610223
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
Ishii Y; Waxman S; Germain D
Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
[TBL] [Abstract][Full Text] [Related]
15. Tracking STAT nuclear traffic.
Reich NC; Liu L
Nat Rev Immunol; 2006 Aug; 6(8):602-12. PubMed ID: 16868551
[TBL] [Abstract][Full Text] [Related]
16. Potential role for STAT3 inhibitors in glioblastoma.
Jackson C; Ruzevick J; Amin AG; Lim M
Neurosurg Clin N Am; 2012 Jul; 23(3):379-89. PubMed ID: 22748651
[TBL] [Abstract][Full Text] [Related]
17. BART is essential for nuclear retention of STAT3.
Muromoto R; Sekine Y; Imoto S; Ikeda O; Okayama T; Sato N; Matsuda T
Int Immunol; 2008 Mar; 20(3):395-403. PubMed ID: 18234692
[TBL] [Abstract][Full Text] [Related]
18. Targeting STAT3 affects melanoma on multiple fronts.
Kortylewski M; Jove R; Yu H
Cancer Metastasis Rev; 2005 Jun; 24(2):315-27. PubMed ID: 15986140
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
